Apteka JAN Kalinka Spółka z Ograniczoną Odpowiedzialnością (KRS 0000449405, NIP 7331347379) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. APTEKA JAN KALINKA operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since February 1, 2013. APTEKA JAN KALINKA's most recently reported net revenue was 45.4 K PLN for 2024.
Negative equity
Negative equity in 2 of 6 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Apteka JAN Kalinka
Identity
- Name
- Apteka JAN Kalinka Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- February 1, 2013
- Registry status as of
- May 10, 2026
- Latest entry
- May 10, 2026
- Founding act
- 06.12.2012R., NOTARIUSZ MAŁGORZATA Z.KRÓL, KANCELARIA NOTARIALNA W ŁODZI, REPERTORIUM A NR 8373/2012
Articles of association history (3)
- December 6, 2012: 06.12.2012R., NOTARIUSZ MAŁGORZATA Z.KRÓL, KANCELARIA NOTARIALNA W ŁODZI, REPERTORIUM A NR 8373/2012
- April 14, 2015: 14.04.2015 R., KANCELARIA NOTARIALNA W ŁODZI, NOTARIUSZ PIOTR KRÓL, REPERTORIUM A NR 723/2015, ZMIENIONO § 3 ORAZ § 7 UMOWY SPÓŁKI.
- November 7, 2017: 07.11.2017 R. NOTARIUSZ MAŁGORZATA Z. KRÓL, KANCELARIA NOTARIALNA W ŁODZI REP. A NR 6566/2017, ZMIANA § 9 UST. 1 UMOWY SPÓŁKI
Activities
Main activity
47.73.ZDispensing chemist in specialised stores
Other activities
Address and contact
- Address
- UL. KINGA C. GILLETTE, 11, 94-406, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-33638-56459-BJFSS-27
- Coordinates
- 51.7768, 19.4547approx.
Risk and payment profile - Apteka JAN Kalinka
Credibility rating
30.1 / 100
Poor credibility
Insolvency risk
Moderate
Significant formal threat
Closure risk
22
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/13 yrs
Board changes
2
2/13 yrs
PKD changes
1
1/13 yrs
Name changes
0
0/13 yrs
Data from 13 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (30/100)
Trend: deteriorating (-11.0 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 448.71 PLN
Safe: 76.28 PLN
Operational status - Apteka JAN Kalinka
Founded
February 1, 2013
13 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
274.7 K PLN
104 shares total
Shareholders
2
shareholders
Board
3 people
Filed years
6 years
2018–2024 · profitable: 3/6
Registry entries
34
latest: May 10, 2026
Risk signals
Revenue
45.4 K PLN
2024
Net profit
-24.0 K PLN
2024
Assets
3.1 M PLN
2024
Equity
2.8 M PLN
2024
EBITDA
4.4 K PLN
2024
Valuation
1.2 M PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Apteka JAN Kalinka.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
